Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income Tax Provision |
The income tax expense consisted of the following (in thousands): | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | 2022 | | 2021 | | 2020 | | Current income tax: | | | | | Federal | $ | — | | | $ | — | | | $ | — | | | State | 2,531 | | | 2,359 | | | 2,174 | | | Foreign | 1,230 | | | 3,641 | | | 764 | | | Total | 3,761 | | | 6,000 | | | 2,938 | | | Deferred income tax: | | | | | Federal | — | | | — | | | — | | | State | 251 | | | (263) | | | (851) | | | Foreign | (1,662) | | | (3,266) | | | (1,004) | | | Total | (1,411) | | | (3,529) | | | (1,855) | | | Income tax expense | $ | 2,350 | | | $ | 2,471 | | | $ | 1,083 | |
|
| Schedule of Reconciliation of Tax Expense Computed at Statutory Federal Rate and Company's Tax Expense |
The following reconciles the tax benefit computed at the statutory federal rate and the Company’s tax expense (in thousands): | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | 2022 | | 2021 | | 2020 | | Computed expected tax benefit | $ | (10,370) | | | $ | (63,647) | | | $ | (126,472) | | | State income taxes, net of federal tax effect | 2,222 | | | 1,556 | | | 882 | | | Foreign income taxes | 20 | | | 221 | | | (383) | | | Other reconciling items | 1,349 | | | (1,235) | | | (714) | | | Sale of Vivint Canada, Inc. | (5,279) | | | — | | | — | | | Capital Loss Limitation | (6,831) | | | — | | | — | | | Permanent differences | (2,520) | | | (8,753) | | | 36,423 | | | Excess deductible compensation limitation | 17,481 | | | 10,463 | | | 9,667 | | | Change in valuation allowance | 6,278 | | | 63,866 | | | 81,680 | | | Income tax expense | $ | 2,350 | | | $ | 2,471 | | | $ | 1,083 | |
|
| Schedule of Significant Portions of Deferred Tax Assets and Liabilities |
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities were as follows (in thousands): | | | | | | | | | | | | | | December 31, | | | 2022 | | 2021 | | Gross deferred tax assets: | | | Net operating loss carryforwards | $ | 510,274 | | | $ | 546,693 | | | Deferred subscriber income | 349,187 | | | 326,759 | | | Interest expense limitation | 161,408 | | | 142,919 | | | Accrued expenses and allowances | 52,010 | | | 56,495 | | | Capitalized Research and Experimental Expenses | 13,917 | | | — | | | Lease liabilities | 10,761 | | | 13,356 | | | Purchased intangibles and deferred financing costs | 8,690 | | | 9,687 | | | Inventory reserves | 2,083 | | | 1,859 | | | Research and development credits | 41 | | | 41 | | | Deferred capitalized contract costs | — | | | 1,800 | | | Property and equipment | 1,672 | | | 1,888 | | | Valuation allowance | (737,374) | | | (740,397) | | | Total | 372,669 | | | 361,100 | | | Gross deferred tax liabilities: | | | Deferred capitalized contract costs | (364,406) | | | (346,887) | | | Right of use assets | (9,153) | | | (11,430) | | | Purchased intangibles and deferred financing costs | — | | | (959) | | | Property and equipment | — | | | (443) | | | | | | | Total | (373,559) | | | (359,719) | | | Net deferred tax assets (liabilities) | $ | (890) | | | $ | 1,381 | |
|
| Summary of Net Operating Loss Carryforwards |
The Company had gross operating loss carryforwards as follows (in thousands): | | | | | | | | | | | | | | December 31, | | | 2022 | | 2021 | | Net operating loss carryforwards: | | | | | Federal | $ | 2,093,641 | | | $ | 2,229,000 | | | States | 1,827,793 | | | 2,036,000 | | | | | | | | | | | Total | $ | 3,921,434 | | | $ | 4,265,000 | |
|